 Brainstorm Cell Therapeutics Inc. NASDAQ:BCLI Q1 2022 Earnings Conference Call May 16, 2022 8:00 AM ET Company Participants Tom Galassi - Investor Relations, LifeSci Advisors Chaim Lebovits - Chief Executive Officer Alla Patlis - Interim Chief Financial Officer Stacy Lindborg - Executive Vice President and Chief Development Officer Ralph Kern - President and Chief Medical Officer David Setboun - Executive Vice President and Chief Operating Officer Conference Call Participants David Bautz - Zacks Small-Cap Research Michelle Lorenz - Voices for ALS Operator Greetings and welcome to the Brainstorm Cell Therapeutics First Quarter 2022 Conference Call. At this time, participants are in a listen-only mode. 